BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34970278)

  • 1. Establishment of a Hyperacute Rejection Model of ABO-Incompatible Renal Transplantation in Nonhuman Primates.
    Wang J; Feng H; Zhang C; Zhong S; Wang L; Zhu L; Chen S; Chen G
    Front Immunol; 2021; 12():807604. PubMed ID: 34970278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized Preconditioning for ABO-Incompatible Living-Donor Kidney Transplantation: An Initial Report of 48 Cases from China.
    Wang XD; Liu JP; Fan Y; Song TR; Shi YY; Li YM; Lv YH; Li XH; Huang ZL; Lin T
    Ann Transplant; 2020 Feb; 25():e920224. PubMed ID: 32029699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single cohort study: ABO-incompatible kidney transplant recipients have a higher risk of lymphocele formation.
    Jänigen BM; Salabè C; Glatz T; Thomusch O; Lässle C; Fichtner-Feigl S; Zschiedrich S; Pisarski P
    Langenbecks Arch Surg; 2019 Dec; 404(8):999-1007. PubMed ID: 31456076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyporesponsiveness against donor's ABO antigens of renal grafts after ABO-incompatible kidney transplantation.
    Tasaki M; Tateno H; Sato T; Narimatsu H; Saito K; Nakagawa Y; Aoki T; Kamimura M; Ushiki T; Takahashi K; Tomita Y
    Clin Exp Nephrol; 2023 Jan; 27(1):89-95. PubMed ID: 36209259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation.
    Toki D; Ishida H; Horita S; Yamaguchi Y; Tanabe K
    Transplantation; 2009 Nov; 88(10):1186-93. PubMed ID: 19935372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO-incompatible pediatric kidney transplantation without antibody removal.
    Kawamura T; Hamasaki Y; Takahashi Y; Hashimoto J; Kubota M; Muramatu M; Itabashi Y; Hyodo Y; Ohashi Y; Aikawa A; Sakai K; Shishido S
    Pediatr Nephrol; 2020 Jan; 35(1):95-102. PubMed ID: 31673829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-Mediated Rejection in a Blood Group A-Transgenic Mouse Model of ABO-Incompatible Heart Transplantation.
    Motyka B; Fisicaro N; Wang SI; Kratochvil A; Labonte K; Tao K; Pearcey J; Marshall T; Mengel M; Sis B; Fan X; dʼApice AJ; Cowan PJ; West LJ
    Transplantation; 2016 Jun; 100(6):1228-37. PubMed ID: 27120451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience.
    Zschiedrich S; Jänigen B; Dimova D; Neumann A; Seidl M; Hils S; Geyer M; Emmerich F; Kirste G; Drognitz O; Hopt UT; Walz G; Huber TB; Pisarski P; Kramer-Zucker A
    Nephrol Dial Transplant; 2016 Apr; 31(4):663-71. PubMed ID: 26610596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Chow KV; Flint SM; Shen A; Landgren A; Finlay M; Murugasu A; Masterson R; Hughes P; Cohney SJ
    Transplantation; 2017 Jun; 101(6):1433-1440. PubMed ID: 27495772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline rejection in ABO-incompatible kidney transplantation.
    Sánchez-Escuredo A; Oppenheimer F; Solé M; Revuelta I; Cid J; Lozano M; Blasco M; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Paredes D; Musquera M; Ercilla G; Campistol JM; Diekmann F
    Clin Transplant; 2016 Aug; 30(8):872-9. PubMed ID: 27146439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Patterns Discriminate Accommodation and Subclinical Antibody-mediated Rejection in Kidney Transplantation.
    Hruba P; Krejcik Z; Stranecky V; Maluskova J; Slatinska J; Gueler F; Gwinner W; Bräsen JH; Wohlfahrtova M; Parikova A; Osickova K; Fronek J; Seda O; Prefertusova L; Honsova E; Viklicky O
    Transplantation; 2019 May; 103(5):909-917. PubMed ID: 30801516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations.
    Ko Y; Kim JY; Kim SH; Kim DH; Lim SJ; Shin S; Kim YH; Jung JH; Park SK; Kwon H; Han DJ
    Ann Transplant; 2020 Oct; 25():e927420. PubMed ID: 33020465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid accomodation of an A1 renal allograft after preconditioning for ABO-incompatible transplantation.
    Allen G; Simpkins CE; Segev D; Warren D; King K; Taube J; Locke J; Baldwin W; Haas M; Chivukula R; Montgomery RA
    Contrib Nephrol; 2009; 162():35-46. PubMed ID: 19001812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations.
    Couzi L; Manook M; Perera R; Shaw O; Ahmed Z; Kessaris N; Dorling A; Mamode N
    Transpl Int; 2015 Oct; 28(10):1205-15. PubMed ID: 26095452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO-incompatible kidney transplantation: first cases in Turkey.
    Tuncer M; Yücetin L; Tekin S; Demirbas A
    Transplant Proc; 2012; 44(6):1703-5. PubMed ID: 22841248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
    Masutani K; Tsuchimoto A; Kurihara K; Okabe Y; Kitada H; Okumi M; Tanabe K; Nakamura M; Kitazono T; Tsuruya K;
    Transplantation; 2017 Jun; 101(6):1416-1422. PubMed ID: 27391195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Pediatric ABO-incompatible Living Kidney Transplantations From 2002 to 2015: An Analysis of the Japanese Kidney Transplant Registry.
    Hattori M; Mieno M; Shishido S; Aikawa A; Ushigome H; Ohshima S; Takahashi K; Hasegawa A;
    Transplantation; 2018 Nov; 102(11):1934-1942. PubMed ID: 29781948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation.
    Koch M; Wiech T; Marget M; Peine S; Thude H; Achilles EG; Fischer L; Lehnhardt A; Thaiss F; Nashan B
    Clin Transplant; 2015 Nov; 29(11):1021-8. PubMed ID: 26333844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients.
    Tomita Y; Iwadoh K; Ogawa Y; Miki K; Kato Y; Kai K; Sannomiya A; Koyama I; Kitajima K; Nakajima I; Fuchinoue S
    PLoS One; 2019; 14(10):e0224203. PubMed ID: 31644555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.